Technology | April 14, 2011

FDA Clears Brachytherapy Treatment Planning Software

April 14, 2011 – The U.S Food and Drug Administration (FDA) has cleared a new brachytherapy treatment planning system for permanent seed implants. The MIM Symphony module, from MIM Software, provides a powerful combination of tools to benefit radiation oncologists working with brachytherapy.

MRI, CT and even molecular imaging can now be seamlessly integrated into treatment planning for increased quality assurance.

“Brachytherapists can now enjoy the same image display, fusion and manipulation tools as their colleagues in radiology, and the same contouring tools as their colleagues performing IMRT – all directly integrated into the brachytherapy treatment planning software,” said Jonathan Piper, director of research and business development at MIM Software.

Key to the software is the new ReSlicer tool. For treatments requiring needle insertions that aren’t precisely perpendicular to the imaging plane, ReSlicer allows images to be quickly and easily reoriented, ensuring accurate planning and dosimetry for otherwise complicated plans. The tool adds confidence and simplicity to breast, lung, liver and other treatments.

“Our goal was to achieve totally flexible seed placement,” Piper said. “The use of ReSlicer in conjunction with thin-slice imaging allows for more precise planning and better orientation of seeds within the patient. In addition, fusion with mo¬dalities such as MRI offers more accurate contouring of targets and the possibility of dose escalation.”

The software seamlessly integrates many of the tools found in MIM Maestro, the company’s radiation oncology product. Using dose accumulation, it can sum a brachytherapy plan with any other DICOM dose file, giving an accurate representation of the full dose delivered to the patient. This can be essential to identifying and compensating for hot spots and underdoses, and provides much more confidence than reviewing two separate dose volume histograms.

Post-implant quality assurance is much more accurate. Multi-modality fusion allows either the original planning image or a separate post-implant image, such as an MRI, to be registered to a post-implant CT for more reliable target contouring. Combined with seed localization accuracy, which exceeds the resolution of the CT image, post-implant dosimetry is both easy and exact.

For more information: www.mimsoftware.com

Related Content

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
This image depicts ABUS images with QVCAD results

This image depicts ABUS images with QVCAD results.

Feature | Breast Imaging | April 12, 2019
Imaging Technology News spoke with Bob Foley, vice president of sales and marketing of QView Medical, Inc.,
Gamma Knife radiosurgery has become the preferred radiation therapy option for patients with brain tumors at facilities like the Northwestern Medicine Cancer Center, pictured here

Gamma Knife radiosurgery has become the preferred radiation therapy option for patients with brain tumors at facilities like the Northwestern Medicine Cancer Center, pictured here. The technology is favored largely for its ability to precisely target tumors while sparing healthy tissue.

Feature | Radiation Oncology | April 11, 2019 | By Jeff Zagoudis
Brain tumors are some of the most complicated forms of cancer to treat due to their extremely sensitive location.
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...